Your browser doesn't support javascript.
loading
Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors.
Felín, Mariangela Soberón; Wang, Kanix; Raggi, Catalina; Moreira, Aliya; Pandey, Abhinav; Grose, Andrew; Caballero, Zuleima; Rengifo-Herrera, Claudia; Ramirez, Margarita; Moossazadeh, Davina; Castro, Catherine; Montalvo, José Luis Sanchez; Leahy, Karen; Zhou, Ying; Clouser, Fatima Alibana; Siddiqui, Maryam; Leong, Nicole; Goodall, Perpetua; Michalowski, Morgan; Ismail, Mahmoud; Christmas, Monica; Schrantz, Stephen; Norero, Ximena; Estripeaut, Dora; Ellis, David; Ashi, Kevin; Dovgin, Samantha; Dixon, Ashtyn; Li, Xuan; Begeman, Ian; Heichman, Sharon; Lykins, Joseph; Villalobos-Cerrud, Delba; Fabrega, Lorena; Mendivil, Connie; Quijada, Mario R; Fernández-Pirla, Silvia; de La Guardia, Valli; Wong, Digna; de LadrónGuevara, Mayrene; Flores, Carlos; Borace, Jovanna; García, Anabel; Caballero, Natividad; de Saez, Maria Theresa Moreno; Politis, Michael; Ross, Stephanie; Dogra, Mimansa; Dhamsania, Vishan; Graves, Nicholas.
Affiliation
  • Felín MS; Toxoplasmosis Programs and Initiatives in Panamá, Ciudad de Panamá, Panama.
  • Wang K; Institute for Genomics and Systems Biology, The University of Chicago, Chicago, IL, USA.
  • Raggi C; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Moreira A; Instituto de Investigaciones Científicas Y Servicios de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama.
  • Pandey A; Department of Pediatrics Infectious Diseases/Department of Neonatology, Hospital del Niño Doctor José Renán Esquivel, Ciudad de Panamá, Panama.
  • Grose A; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Caballero Z; The College, The University of Chicago, Chicago, IL, USA.
  • Rengifo-Herrera C; The Global Health Center, The University of Chicago, Chicago, IL, USA.
  • Ramirez M; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Moossazadeh D; The College, The University of Chicago, Chicago, IL, USA.
  • Castro C; The Global Health Center, The University of Chicago, Chicago, IL, USA.
  • Montalvo JLS; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Leahy K; The College, The University of Chicago, Chicago, IL, USA.
  • Zhou Y; The Global Health Center, The University of Chicago, Chicago, IL, USA.
  • Clouser FA; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Siddiqui M; Instituto de Investigaciones Científicas Y Servicios de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama.
  • Leong N; Universidad de Panamá, Ciudad de Panamá, Panama.
  • Goodall P; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Michalowski M; The College, The University of Chicago, Chicago, IL, USA.
  • Ismail M; The Global Health Center, The University of Chicago, Chicago, IL, USA.
  • Christmas M; The College, The University of Chicago, Chicago, IL, USA.
  • Schrantz S; The Global Health Center, The University of Chicago, Chicago, IL, USA.
  • Norero X; Department of Statistics, The University of Chicago, Chicago, IL, USA.
  • Estripeaut D; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Ellis D; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Ashi K; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Dovgin S; The College, The University of Chicago, Chicago, IL, USA.
  • Dixon A; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Li X; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Begeman I; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Heichman S; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Lykins J; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Villalobos-Cerrud D; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Fabrega L; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Mendivil C; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Quijada MR; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Fernández-Pirla S; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • de La Guardia V; Department of Pediatrics Infectious Diseases/Department of Neonatology, Hospital del Niño Doctor José Renán Esquivel, Ciudad de Panamá, Panama.
  • Wong D; Department of Pediatrics Infectious Diseases/Department of Neonatology, Hospital del Niño Doctor José Renán Esquivel, Ciudad de Panamá, Panama.
  • de LadrónGuevara M; Department of Pediatrics Infectious Diseases/Department of Neonatology, Hospital del Niño Doctor José Renán Esquivel, Ciudad de Panamá, Panama.
  • Flores C; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Borace J; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • García A; The College, The University of Chicago, Chicago, IL, USA.
  • Caballero N; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • de Saez MTM; Rush University Medical School/Rush University Medical Center, Chicago, IL, USA.
  • Politis M; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Ross S; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Dogra M; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  • Dhamsania V; Department of Ophthalmology and Visual Sciences, The University of Chicago, Chicago, IL, USA.
  • Graves N; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
Curr Pediatr Rep ; 10(3): 109-124, 2022 Sep.
Article in En | MEDLINE | ID: mdl-37744780
Purpose of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary: Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Language: En Journal: Curr Pediatr Rep Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Language: En Journal: Curr Pediatr Rep Year: 2022 Document type: Article